A victory for our patients.
Over the past two decades, the FDA has repeatedly removed necessary safeguards on the chemical abortion drugs mifepristone and misoprostol. These deregulations have placed women and girls at greater risk of life-threatening complications, as well as coerced abortion by abusers and traffickers. Today’s ruling by the Fifth Circuit Court of Appeals reinstating these basic safeguards and stopping the dangerous practice of mail-order abortions is a first step towards reprioritizing women’s health over the interests of the abortion industry and its allies within our profession. As physicians, we will continue to fight for all our patients to be able to receive the best fully informed and evidence-based healthcare possible.